The content on this site is intended for healthcare professionals only
Dr Jayant Vaidya speaks to ecancer about single-dose intraoperative radiotherapy (IORT) during lumpectomy for breast cancer as being an innovative patient-centred treatment.
He explains a paper was written to review all the current modern radiotherapy techniques. These included whole breast radiotherapy techniques, partial breast radiotherapy techniques as well as the decision to not give any radiotherapy to patients at all.
Dr Vaidya concludes IORT demonstrated the benefits of low recurrence rates and allowed the avoidance of scattered radiation therefore improving overall survival for breast cancer patients.
Read the full study here.
Visit the TARGIT website here.
Breast and emerging indications for IORT
The advantages of IORT for early breast cancer treatment
The pros and cons of breast IORT and ultra hypofractionation (FR)
Global adoption of single-shot targeted IORT for breast cancer
IORT at the Asian Hospital and Medical Center
The TARGIT-A randomised trial: TARGIT-IORT versus whole breast radiation therapy: long-term local control and survival
Insights from TARGIT-A trial of targeted IORT during lumpectomy for breast cancer
Gemcitabine, cisplatin plus nivolumab achieves clinical complete response in subset of muscle-invasive bladder cancer patients
The advancements in radiotherapy for breast cancer patients
